Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer
The study reports completion of a clinical trial focused on management strategies for patients with cirrhosis and esophagogastric varices wh…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: MRinRT: Swansea University and SWWCC Collaboration Study.
The MRinRT Swansea University and SWWCC collaboration study updates on MRI-guided adaptive radiotherapy and is not yet recruiting, with mult…
-
EMA approval · 2026-01-23EMA Authorised: Ontruzant (trastuzumab) — Samsung Bioepis NL B.V.
EMA authorised Ontruzant (trastuzumab) from Samsung Bioepis NL B.V., a biosimilar to trastuzumab for breast and gastric cancers.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating the safety and tolerability of Study Drug as third-line and beyond therapy for recurrent or metastatic gastr…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates IBI363 plus bevacizumab with or without nab-paclitaxel as second-line treatment for advanced gastric…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors [Phase 1]
Phase 1 clinical trial update for a CEA-targeting CAR-T therapy (PTC13) in CEA-positive advanced malignant solid tumors, currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Prolonged Extubation in Gastric Cancer With OSA
This ClinicalTrials.gov entry describes an ongoing, invitation-only trial investigating prolonged extubation in patients with gastric cancer…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 3]
A Phase 3 clinical trial update for LM-108 in combination with toripalimab versus paclitaxel for CCR8-positive gastric and gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [Phase 2]
Phase 2 study evaluating the PET imaging agent [18F]FAPI-74 in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: First in Human Study of QLS5316 in Solid Tumors [Phase 1]
This is a first-in-human Phase 1 trial of QLS5316 in various solid tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating OCT-598 in patients with advanced solid tumors; the study is currently recruiting and includes multiple tu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
A Zhejiang University-sponsored clinical trial (NCT07359586) is currently recruiting to evaluate laryngopharyngeal injury after endotracheal…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]
Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal c…
-
CLINICAL_TRIALS other · 2026-01-22Clinical Trial Update: JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma. [Phase 3]
Phase 3 clinical trial evaluating JS107 versus investigator's choice as second-line or later therapy for CLDN18.2-positive advanced gastric …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer [Phase 2]
Phase 2 trial comparing oral cryotherapy with acupressure/acupuncture versus oral cryotherapy alone to prevent oxaliplatin-induced periphera…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating a PD-1 antibody in combination with chemotherapy or targeted therapy, followed by a surgery-centric local …
-
CLINICAL_TRIALS withdrawal · 2026-01-21Clinical Trial Update: Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b [Phase 2]
A Phase 2 trial evaluating bemarituzumab in combination with FLOT chemotherapy for perioperative treatment of FGFR2b-overexpressing gastric/…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [EARLY_Phase 1]
An early-phase (Phase 1) study evaluating pucotenlimab in combination with lenvatinib and the SOX regimen versus SOX alone in HER2-negative …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorec…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cabozantinib plus durvalumab with or without tremelimumab in patients with gastroesophageal cancer and o…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) [Phase 2]
A Phase 2 trial (VIKTORY-2) is evaluating the combination of savolitinib and durvalumab in MET-amplified advanced gastric cancer and is curr…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Gastric Cancer Prevention for Indigenous Peoples [NA]
A clinical trial update indicating that recruitment is ongoing for a gastric cancer prevention study focusing on Indigenous peoples.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab with capecitabine and radiation therapy for mismatch-repair deficient and Epstein-Barr virus…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy [NA]
This clinical trial update describes evaluating remimazolam to reduce postoperative delirium in elderly gastric cancer patients undergoing l…